top of page
Browse by category
Search
Apollo’s ESG and REVISE Systems approved by FDA
Apollo Endosurgery has been granted marketing authorisation for its ESG, ESG Sx, REVISE and REVISE Sx through the FDA’s De Novo...
ReShape's Vernon Vincent to be Recognized as ASMBS Distinguished Industry Partner
ReShape Lifesciences™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that...
Ethicon launches next generation Echelon 3000 stapler designed for exceptional access and control
Ethicon, part of Johnson & Johnson MedTech, has launched the ECHELON 3000 Stapler in the US. According to the company, this digitally...
ReShape and OpenLoop sign agreement to provide physician-led virtual weight loss coaching
ReShape Lifesciences and OpenLoop, an expert in full-stack virtual care delivery services, have announced the signing of an agreement to...
Remote Patient Management: Helping bariatric departments track and support patients in the long term
Bariatric departments can face many challenges, chief among them is how to manage and track their patients through a long pre-operative...
FDA approves Eli Lilly’s Mounjaro (tirzepatide) for adults with T2DM
The FDA has approved Mounjaro (tirzepatide, Eli Lilly and Company) injection to improve blood sugar control in adults with type 2...
‘Get Ready®’ for the digitisation of the bariatric patient pathway
How digitisation is enabling Bariatric Care Teams to remotely prepare their patients for surgery and assist them through their weight...
Altimmune begins MOMENTUM obesity trial for Pemvidutide
Altimmune has enrolled the first subject in the 48-week Phase 2 MOMENTUM trial evaluating the safety and efficacy of pemvidutide in...
Oxford Medical Products gains £2.5 million funding for weight-loss hydrogel technology
Oxford Medical Products has raised £2.5M in equity investment to conduct the first human trials of Sirona, its weight-loss platform....
Aspire Bariatrics withdraws AspireAssist from the market as COVID takes its toll
Aspire Bariatrics is closing all operations and, as a consequence, is withdrawing the controversial AspireAssist from the market,...
Browse by tag
bottom of page